SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant post-earnings volatility driven by the surprise announcement of CEO Shantanu Narayen's upcoming departure and ongoing investor skepticism regarding its ability to monetize AI against emerging generative competitors. While the company posted a double beat on revenue and earnings, the community remains sharply divided between those viewing the pullback as a buying opportunity given the firm's strong cash flow and those fearing that AI-driven tools will permanently erode its market share.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is drawing heavy community attention following an upbeat commercial outlook for its fibromyalgia treatment, Tonmya, which has triggered debates over potential short squeezes and institutional accumulation. While some investors remain cautious due to the company's historical share dilution and ongoing cash burn, bulls are focused on the accelerating prescription growth and the company's recent uplisting to the Nasdaq Global Select Market.

Trump For President

The $TRUMP crypto token is currently facing intense volatility and skepticism as community members debate its long-term viability, with many investors expressing frustration over recent price declines. The discourse is heavily polarized, fueled by heated political debates and accusations regarding the project's association with broader controversies, while some supporters continue to frame the asset as a speculative opportunity.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant downward pressure as investors rotate out of growth stocks, while the community remains divided between those panic-selling and those viewing the recent price drop as a strategic buying opportunity supported by institutional interest from firms like ARK Invest. The ongoing conversation is dominated by frustration over the stock's inability to hold gains, persistent short-selling activity, and the search for a definitive bottom amidst broader market uncertainty.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Market sentiment for SPY is heavily driven by intensifying geopolitical instability in the Middle East and concerns over surging energy costs, with traders closely monitoring the potential impact on global supply chains and inflation. Community discussions are currently polarized, featuring heated debates on the economic consequences of U.S. policy decisions, skepticism toward short-term relief measures like Russian oil purchases, and active speculation on whether upcoming economic data will sustain or break current price trends.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is seeing heightened investor attention following a new development agreement with Tower Semiconductor to integrate its proprietary electro-optic polymer modulators into the PH18 silicon photonics platform for high-performance AI and networking applications. Community members remain polarized, with long-term supporters highlighting the potential for widespread industry adoption in data centers, while skeptics continue to voice concerns regarding the company's lack of significant revenue and the history of stock dilution.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending due to the official enrollment of the first patient in a Phase 2 trial for SLS009, an asset the community views as a major valuation driver for a potential buyout alongside the ongoing REGAL Phase 3 study. While some investors remain focused on the potential for an imminent partnership or acquisition, others are debating the impact of warrant exercises and trial timelines on the near-term share price.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is facing intensified market pressure as investors debate the impact of geopolitical conflicts, energy price volatility, and the launch of new institutional products. While some market participants see the ongoing consolidation and institutional interest as a potential setup for a trend reversal, others remain focused on bearish technical indicators and the vulnerability of risk assets during periods of macro uncertainty.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is experiencing extreme volatility and massive trading volumes as the escalating conflict in the Middle Eastspecifically surrounding the Strait of Hormuzdrives fears of a historic global supply shock. While the community remains sharply divided, traders are actively debating whether current price levels are sustainable given potential supply-side interventions and conflicting signals regarding future oil tanker safety.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines ($UMAC) is drawing significant market attention as a key domestic supplier in the defense drone sector, bolstered by its role in the U.S. government's 'Drone Dominance' program and strategic investor ties. Community discussion centers on its potential as a 'picks and shovels' play, with traders highlighting high volatility, rapid production scaling in Florida, and the stock's tendency to react sharply to government contract news and defense industry momentum.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arrowstreet Capital Limited Partnership Has $1.17 Billion Stock Position in UnitedHealth Group Incorporated $UNH

Arrowstreet Capital Limited Partnership increased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 17.3% in the 3rd quarter, according to the company in its most recent 13F...

Advisory Research Inc. Has $896,000 Stock Holdings in UnitedHealth Group Incorporated $UNH

Advisory Research Inc. cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 89.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The...

UnitedHealth Group (NYSE:UNH) Trading Down 2.8% - Here's What Happened

UnitedHealth Group (NYSE:UNH) Stock Price Down 2.8% - Should You Sell...

Dividend Stocks To Follow Now - March 12th

Chevron, UnitedHealth Group, Blackstone, Verizon Communications, Accenture, AbbVie, and DOW are the seven Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend...

Best Medical Stocks To Watch Now - March 12th

UnitedHealth Group, Hims & Hers Health, Eli Lilly and Company, Johnson & Johnson, and Stryker are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks...

Healthcare Stocks To Consider - March 12th

UnitedHealth Group, Hims & Hers Health, and Johnson & Johnson are the three Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly...

Nemes Rush Group LLC Cuts Stake in UnitedHealth Group Incorporated $UNH

Nemes Rush Group LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 99.4% in the third quarter, according to its most recent filing with the Securities and...

Rep. Gilbert Ray Cisneros, Jr. Sells Off Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on March 09th, the Representative disclosed...

Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene 

 UnitedHealth, The Cigna, Humana and Centene have been highlighted in this Industry Outlook article.


Bokf Na Sells 4,082 Shares of UnitedHealth Group Incorporated $UNH

Bokf Na cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange...

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$6.81	--	--	N/A
Q4 '25	$2.11	$2.11	0.19%	BEAT
Q3 '25	$2.80	$2.92	4.46%	BEAT
Q2 '25	$4.48	$4.08	-8.94%	MISSED
Q1 '25	$7.30	$7.20	-1.31%	MISSED

UNH
Unitedhealth Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest UNH News

UNHUnitedhealth Group Inc